XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect of ASC 326 adoption
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Cumulative effect of ASC 326 adoption
Beginning Balance, Stockholders' equity (in shares) at Dec. 31, 2021     27,505        
Beginning Balance, Stockholders' equity at Dec. 31, 2021 $ 131,907 $ (401) $ 27 $ 223,336 $ (4,457) $ (86,999) $ (401)
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)     98        
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes 156     156      
Stock-based compensation 2,671     2,671      
Net loss (As Restated) (7,586)         (7,586)  
Subsidiary dissolution (68)       (68)    
Other comprehensive loss (268)       (268)    
Ending Balance, Stockholders' equity (in shares) at Mar. 31, 2022     27,603        
Ending Balance, Stockholders' equity at Mar. 31, 2022 $ 126,411   $ 27 226,163 (4,793) (94,986)  
Beginning Balance, Stockholders' equity (in shares) at Dec. 31, 2022 30,968   30,968        
Beginning Balance, Stockholders' equity at Dec. 31, 2022 $ 138,582   $ 30 271,884 (4,662) (128,670)  
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)     134        
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (87)   $ 1 (88)      
Stock-based compensation 4,486     4,486      
Net loss (As Restated) (23,817)         (23,817)  
Other comprehensive loss $ (1,949)       (1,949)    
Ending Balance, Stockholders' equity (in shares) at Mar. 31, 2023 31,102   31,102        
Ending Balance, Stockholders' equity at Mar. 31, 2023 $ 117,215   $ 31 $ 276,282 $ (6,611) $ (152,487)  
Accounting Standards Update [Extensible Enumeration] Cumulative effect of ASC 326 adoption